NCT00164840View on ClinicalTrials.gov

Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy

PHASE3CompletedINTERVENTIONAL

Enrollment

244

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Esomeprazole

Trial Locations (1)

Unknown

Endoscopy Centre, Prince of Wales Hospital, Hong Kong

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER

NCT00164840 - Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy | Biotech Hunter | Biotech Hunter